Mental health care in the United States has a big shortage of staff and more patients need help. Dr. Ross Harper, co-founder of Limbic, says there are not enough trained mental health workers to meet all the demand. AI tools can help by making clinics work better and helping patients get care. But these tools need patients to say yes before they can be used well.
Doctors have been careful about using AI because they worry about mistakes called “hallucinations” that AI might make. They also fear it might make the patient-doctor relationship harder. For example, general doctors correctly diagnose depression in about half of cases, showing it is a hard task and AI could help. Still, some patients do not want to use AI tools, maybe because they worry about privacy or do not trust the technology.
In the U.S., early programs showed only about 25% of patients would say yes to AI screening in mental health clinics. But a U.S. startup called Kintsugi found that more patients agree when the tool fits what patients expect and works well with current clinic routines.
Kintsugi made a voice analysis AI system that looks for signs of depression and anxiety by listening to how patients speak. It does not look at texts but studies speech patterns linked to mental health.
They tested this with a large U.S. insurer. Here, 80% of patients agreed to the screening, much higher than 25%. This shows some important reasons:
For healthcare leaders, this shows that teaching patients, keeping workflows simple, and showing clear benefits can help raise patient consent for AI tools.
In the U.K., a startup named Limbic created Limbic Access, an AI tool for mental health screening called e-triage. Even though it is from the U.K., the tool has useful ideas for American clinics that want more patient consent and better mental health care.
Here are some features of Limbic Access:
While it is new in the U.S., Limbic Access is a good example of how AI can improve mental health screening and increase patient trust through better results and fewer delays.
Even with these advances, leaders in U.S. healthcare must think about problems besides patient consent:
U.S. health systems are very different in size and technology. Big medical groups or hospitals can use AI to reduce doctor workloads and help people in remote or poor areas. Smaller clinics may need easy-to-use tools and help to teach patients about AI.
One big strength of AI tools in mental health clinics is making front-office work and clinical tasks run smoothly.
AI-driven phone systems, like those from Simbo AI, can schedule appointments, answer patient questions, and handle triage calls without needing a person all the time. This front-office help has some benefits for patient consent and engagement:
AI can also gather patient information from different places and give doctors reports that point out possible mental health worries. This helps doctors act fast, avoid missed diagnoses, and build patient trust in care.
Learning from Limbic and Kintsugi, medical leaders in the U.S. can try some practical steps to improve patient consent and clinic operations:
Recent progress in AI mental health tools shows they can help patients get care faster, lower doctor workloads, and most importantly, get more patients to agree to use digital health tools. Companies like Kintsugi, with voice analysis, and Limbic, with e-triage, show ways for U.S. clinics to use AI carefully and well. With good patient talks and smart workflow tools, clinics can meet more mental health needs while keeping patient trust and involvement.
AI tools help screen for mental health conditions, aiding in assessing the severity and urgency of patients’ needs, thus addressing the patient overload in mental health care.
Limbic Access is a diagnostic e-triage tool that has screened over 210,000 patients with 93% accuracy across common mental disorders, helping clinicians reduce misdiagnosis and improve treatment efficiency.
Kintsugi uses an AI-powered voice analysis tool to detect clinical depression and anxiety through speech clips, focusing on vocal patterns rather than text-based assessments.
In a case study, 80% of patients consented to be screened by Kintsugi’s tool, significantly surpassing initial estimates of 25% consent.
The mental health field struggles with funding and a shortage of professionals, where general practitioners accurately diagnose depression only about 50% of the time.
Limbic Access is classified in the U.K. as a Class II medical device, recognized for its medium risk and clinical responsibility capabilities.
Limbic Access saves clinicians an estimated 40 minutes per assessment, allowing them to see more patients and reduce waitlists.
Clinicians worry about AI hallucinations and the potential to overwhelm patients with technology, complicating the integration of AI into care.
Kintsugi emphasizes the importance of vocal delivery, using data from 250,000 voice journals to identify ‘voice biomarkers’ that signal mental health conditions.
Kintsugi’s founders faced difficulties in securing therapy appointments, motivating them to create solutions addressing visibility and accessibility in mental health care.